Medidata is a unified platform for clinical research, officially positioned to support smarter clinical trials through unified data, AI-driven insights, and patient-centric technology, thereby accelerating research.
Purpose
The platform is used to manage clinical research, synchronizing study, patient, and data workflows. The official statement notes that managing clinical research requires not an isolated system, but an intelligent platform capable of synchronizing study, patient, and data workflows. The platform features an AI companion and trial orchestrator called Dot, used to address complexity and automate workflows to accelerate the development of life-changing treatments.
Main Capabilities
The platform covers multiple functional areas, and the officially listed solutions include:
- Clinical Trial Financial Management: data-driven financial management
- CTMS: Clinical Trial Management System
- eTMF: electronic Trial Master File
- Grants Manager: site budgets
- Protocol Optimization: smarter study design
- Site Payments: global payment solutions
- Study Feasibility: clinical trial analytics
- Synthetic Control Arm®: intelligent external control arm
- eCOA: electronic Clinical Outcome Assessment
- Consent: informed consent and recruitment for clinical trials
- Decentralized Clinical Trials: flexible, hybrid trials
- Medidata Diversity Program: trial diversity solutions
- myMedidata: patient portal
- myMedidata Registries: pre-trial and post-trial patient engagement
- Patient Payments & Travel: stipends, reimbursement, and concierge services
- Sensors: digital measurement
- Adjudicate: endpoint adjudication
- Clinical Data Studio: data quality management
- Coder+: automated medical coding
- Companion: eSource/EHR to EDC
- Designer: central study build hub
- Health Record Connect: healthcare data interoperability
- Imaging: medical imaging management
- Link: linking trial data with real-world data
- Rave: electronic data capture
- Rave Lite: for Phase I, Phase IV, and MedTech's EDC
- RTSM: Randomization and Trial Supply Management
- Safety Gateway: Automated safety case transmission
- Site Cloud: End of Study: Archiving of site documents during the study closeout phase
- Surgical Planning: Collaborative surgical planning
- Targeted SDV: Risk-based source data verification
The platform also provides customer success services, including strategy and transformation consulting, study configuration services, integrated evidence (real-world data insights), patient insights programs (data-driven insights into barriers to participation), site insights programs (built-in real-world feedback), and patient payments (payments and reimbursement).
The platform is organized around three interconnected experiences: Study Experience, Patient Experience, and Data Experience. Study Experience focuses on how to simulate outcomes throughout the study lifecycle to design and execute with confidence; Patient Experience focuses on how to increase engagement and collaboration at every stage of the trial; Data Experience focuses on how AI can automate and connect data workflows while ensuring rigorous quality.
How to Use
The official page provides a platform exploration entry point, fact sheets, reports, webinars, and more insights, and notes that if you have questions or would like to learn about pricing or next steps, you can contact an expert. The page also offers an on-demand webinar, "From Pilots to Practice: Scaling AI Across Clinical Trials," featuring experts from Worldwide Clinical Trials, Everest Group, and Medidata. Specific product activation, deployment, and integration methods are not yet provided in the materials.
Use Cases
The platform is aimed at sponsors and CROs and covers multiple therapeutic areas. The official examples include: ICON leverages a unified data platform to accelerate decision-making and conduct real-time data review; PROMETRIKA uses the RTSM solution to gain a competitive advantage; Everest Clinical Research uses Medidata to scale and better support clients; a Phase III glioblastoma trial achieved a breakthrough with Synthetic Control Arm®, whose design received FDA recognition, with most patients coming from an external control group. The official materials also mention: Nordic Bioscience uses Rave TSDV to streamline monitoring; a global CRO completed study setup in four to six weeks; a midsize sponsor increased the number of sites by 50% in a rare disease clinical trial.
Limitations
The materials do not provide information such as the platform's specific fee standards, pricing plans, deployment limitations, or usage thresholds. The text mentions that you can contact an expert to learn about pricing and next steps, but does not give specific prices. The specific operating steps and technical requirements for some features are not yet provided in the materials.